EPIM
EDIT icon

Evelyn Partners Investment Management’s Editas Medicine EDIT Stock Holding History

Evelyn Partners Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,200
Closed -$1.39K – 425
2025
Q1 		$1.39K Sell
1,200
-750
-38% -$1.1K ﹤0.01% 395
2024
Q4 		$2.48K Buy
+1,950
New +$4.97K ﹤0.01% 389

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Evelyn Partners Investment Management's EDIT Position: Q2 2025 in Review

Evelyn Partners Investment Management sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 1,200 shares — an estimated $1.39K sold.

Evelyn Partners Investment Management first reported a position in EDIT in Q4 2024 and held it in 2 quarters. The position peaked at $2.48K in Q4 2024. 194 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Evelyn Partners Investment Management reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Evelyn Partners Investment Management sold 1,200 Editas Medicine shares in Q2 2025, an estimated $1.39K.
  • Evelyn Partners Investment Management first reported a position in Editas Medicine in Q4 2024 and held it in 2 quarters.
  • Evelyn Partners Investment Management's Editas Medicine position peaked at $2.48K in Q4 2024.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Evelyn Partners Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.